Cytokinetics (CYTK) PT Raised to $63 at Raymond James
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $75.87 +2.35%
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Raymond James analyst Dane Leone raised the price target on Cytokinetics (NASDAQ: CYTK) to $63.00 (from $54.00) while maintaining a Outperform rating.
You May Also Be Interested In
- H.C. Wainwright Reiterates Buy Rating on Cytokinetics (CYTK)
- JPMorgan Upgrades Hyundai Marine and Fire Insurance (001450:KS) to Neutral
- JD Logistics Inc (2618:HK) (JDLGF) PT Raised to HK$18.50 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
